DAY 2 ✦ Tuesday, August 15 - EST/EDT (Eastern Daylight, GMT-4)
- Matthew Malachowski, Pharm.D., MHA, BCPS - System Director, Population Health & Ambulatory Care Pharmacy, Ochsner Health Pharmacy
- Jerry Taglianetti - Senior Director, Biosimilar Strategic Marketing Team Lead, Amneal Pharmaceuticals
Analysis and strategy around optimal care
Goals and insight to future of healthcare
Strategies to focus on long-term value and strong health equity
- Kathy Oubre, MS - Chief Executive Officer, Pontchartrain Cancer Center
- Kevin Cast - Partner, Archbow Consulting
- Tanmayi Gupta - Associate Director of Specialty Pharmacy, Boston Medical Center
Having the right data, analytics and insights, field team skills, and customer profiles can help progress customer relationships from transactional to partnership. Many biopharma companies have developed successful collaborations with health systems, and many aspire to partner but don’t understand the process and capabilities required. This discussion will touch on those CSFs and how to successfully engage this complex evolving customer segment
- Chris Lisanti - Managing Director, Syneos Health
- Aaron Davis - Managing Director, Commercial Advisory Group, Syneos Health
- Tony Lanzone - Executive Managing Director, Consulting, Syneos
- Adrian Garcia - Executive Vice President, Syneos
- Chirag Desai, MBA, RPh - Director of Pharmacy Outcomes and Data Management, Baptist Health System
- Steven Hosier - Analytics Leader, System Pharmacy, Baptist Health System
- Barry Greene - Pharmacy Decision Support Analyst, Baptist Health System
- Strategies to improve payer-provider relationships and collaboration
- Critical to understand the economics to strengthen the relationship
- Brady Atherton - VP Integrated Rx & Innovation, Prime Therapeutics
- Jerry Buller, DPh, MMHC - Vice President, Payor Access, Loopback Analytics
- Raising awareness and interest in a disease area that is not top of mind is a common problem for the marketing of brands for rare diseases and rare disease funding
- What are engagement mechanisms? Why is it critical to invest and remove barriers? How can we address ways in which resources can be better allocated?
- Update: Biden Administration Executive Order to combat drug pricing
- Jeff Livingstone - CEO, Igia Pharmaceuticals
- Elizabeth Cherry - Program Director for Trade Relations, Vanderbilt Specialty Pharmacy
- Successful pharma sales strategy requires an understanding of the behaviors and product needs of different Integrated Delivery Networks.
- How to approach a health system more effectively and develop a compelling value proposition
- Shifts pharma needs to adopt
- Assess and understand Integrated Delivery Network operational priorities and needs to deliver value-driven engagement
- Applying data-driven strategies
- Danielle Bryan - Clinical Pharmacist, Trade Relations, Vanderbilt Specialty Pharmacy
- Jennifer Scanlon - Assistant Vice President, Global Strategic Partnerships, Northwell Health
Motivation of hospitals and physicians to integrate vertically
Impact of hospital-physician integration on prices, spending, and quality for patient care
Implications of hospital-physician integration for partnerships between pharmaceutical companies and health systems
- Gary Young, JD, PhD - Director of Northeastern University Center for Health Policy and Healthcare Research, Professor of Strategic Management and Healthcare Systems, Northeastern University